Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder

被引:49
|
作者
Storch, Eric A. [1 ,2 ]
Merlo, Lisa J. [1 ]
Larson, Michael J. [3 ]
Marien, Wendi E. [1 ]
Geffken, Gary R. [1 ,2 ]
Jacob, Marni L. [1 ]
Goodman, Wayne K. [1 ]
Murphy, Tanya K. [1 ]
机构
[1] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA
关键词
D O I
10.1016/j.comppsych.2007.06.009
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The objective of the study was to identify clinical and sociodemographic characteristics that may differentiate youth with obsessive-compulsive disorder (OCD) who are resistant to treatment vs those who have a favorable response. Method: Participants included 60 outpatients, aged 7-17 years, who were determined to have previously received an adequate trial of a first-line treatment (ie, serotonin reuptake inhibitors, cognitive behavioral therapy). Patients who were treatment-resistant were compared with responders on a number of factors, including severity and nature of OCD symptoms, levels of internalizing and extemalizing symptoms, family accommodation of OCD symptoms, and functional impairment. Results: The treatment-resistant group endorsed significantly more obsessions and compulsions, greater levels of internalizing symptoms, higher parental stress related to accommodation, and greater functional impairment than treatment responders. However, relative to treatment-resistant patients, treatment responders reported higher levels of depressive symptoms, perhaps indicating that they were more distressed by their OCD symptoms, as well as greater insight into their symptoms. Conclusions: This study indicates that youth with more severe symptoms of OCD, higher related parental stress, and greater functional impairment tend to be more resistant to first-line treatments, and that perhaps they may require more intensive or family-based interventions. Treatment responders report more depressive symptoms and insight into their OCD, which may suggest a greater readiness for treatment. Further research likely would help to identify which types of treatment would be most beneficial for individual youth. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [1] Treatment-resistant obsessive-compulsive disorder
    Pallanti, S.
    Bernardi, S.
    Castellini, G.
    Quercioli, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S209 - S209
  • [2] Treatment-Resistant Obsessive-Compulsive Disorder: Neurocognitive and Clinical Correlates
    Dinn, Wayne M.
    Aycicegi-Dinn, Ayse
    Goral, Fatma
    Darkal, Ola
    Yildirim, Ejder Akgun
    Hacioglu, Munevver
    FUTURE ACADEMY MULTIDISCIPLINARY CONFERENCE ICEEPSY & CPSYC & ICPSIRS & BE-CI, 2016, 217 : 1189 - 1198
  • [3] Treatment-Resistant Obsessive-Compulsive Disorder: Clinical and Personality Correlates
    Dinn, Wayne M.
    Aycicegi-Dinn, Ayse
    Goral, Fatma
    Yildirim, Ejder Akgun
    Hacioglu, Munevver
    5TH WORLD CONFERENCE ON PSYCHOLOGY, COUNSELING AND GUIDANCE, WCPCG-2014, 2014, 159 : 239 - 242
  • [4] Quetiapine in treatment-resistant obsessive-compulsive disorder
    Cohen, LS
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (06): : 623 - 624
  • [5] Citalopram for treatment-resistant obsessive-compulsive disorder
    Pallanti, S
    Quercioli, L
    Paiva, RS
    Koran, LM
    EUROPEAN PSYCHIATRY, 1999, 14 (02) : 101 - 106
  • [6] Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Friedberg, J
    Wasserman, S
    Allen, A
    Birnbaum, M
    Koran, LM
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (05) : 546 - 550
  • [7] Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder
    Kayser, Reilly R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
  • [8] Management of Treatment-Resistant Obsessive-Compulsive Disorder
    Gershkovich M.
    Wheaton M.G.
    Simpson H.B.
    Current Treatment Options in Psychiatry, 2017, 4 (4) : 357 - 370
  • [9] Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Friedberg, J
    Wasserman, S
    Allen, A
    Koran, LM
    Birnbaum, M
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 206S - 207S
  • [10] Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
    Koran, LM
    Ringold, AL
    Elliott, MA
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (07) : 514 - 517